Getting To Implementation: Improving Cancer Screening for Veterans

Not Applicable

• Conditions: Cancer of Liver; Cirrhosis; Cancer of Colon

• Registration Number: NCT06458998
• Lead Sponsor: University of Pittsburgh

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-5-31
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Enrolling by invitation
• Sex: All
• Target Recruitment: 30300

Inclusion Criteria

Inclusion Criteria:<br><br> 1. Veterans:<br><br> - =18 years of age<br><br> - Enrolled in Veterans Health Administration (VA)<br><br> - Have =1 VA encounter in the prior 18 months<br><br> - Hepatocellular cancer (HCC) screening subgroup: Diagnosis of cirrhosis in<br> electronic medical record<br><br> - Colorectal cancer (CRC) screening subgroup: =45 years of age, positive fecal<br> immunochemical test (FIT) (or other screening stool test) in the last 18 months<br><br> 2. Providers:<br><br> - Healthcare provider or related staff at participating VA site or engaged in CRC<br> or HCC screening pathways in an included VA site (e.g., scheduling)<br><br> - =18 years of age<br><br>Exclusion Criteria:<br><br> 1. Veterans:<br><br> - <18 years of age<br><br> - Not enrolled in VA<br><br> - No VA encounters in the prior 18 months<br><br> - Limited life expectancy (< 6 months), defined as having a code for hospice<br><br> 2. Providers:<br><br> - Members of the study team will not participate, even if their sites are<br> recruited

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in Reach of HCC screening from Baseline to 12 months;Change in Reach of CRC screening from Baseline to 12 months

Secondary Outcome Measures

Name	Time	Method
Effectiveness of screening - Change in the number of tumor/polyp/lesions detected from Baseline to 12 months;Effectiveness of screening - Change in time to treatment from Baseline to 12 months;Change in Adoption of screening from Baseline to 12 months;Feasibility of intervention assessed by the Feasibility of Intervention measure (FIM);Acceptability assessed by the Acceptability of Intervention Measure (AIM);Appropriateness assessed by the Intervention Appropriateness Measure (IAM);Fidelity - Proportion of Veterans receiving recommended screening;Maintenance of HCC Screening at 18 and 24 months from Baseline;Maintenance of CRC Screening at 18 and 24 months from Baseline